US President Donald Trump imposed 100% tariffs on pharmaceutical imports, a move which may impact 'pharmacy of the world' India. India's total global pharma exports stood at $30 billion in 2024-25, with US accounting for 31% exports. While Trump's order targets patented drugs, which multinationals dominate, concerns remain that India's complex generics and specialty medicines may also be tariffed.